01833nam a2200397 a 4500001001200000003000800012006001900020007001500039008004100054010001700095020002500112020002200137040002100159035002100180043001200201050002500213082001900238245027400257260005800531300003700589500005800626504005400684530004300738533015200781650005500933650006100988650004601049655002901095700002101124700001801145700002201163710009001185710001701275856012601292999001701418ebr10225174CaPaEBRm        u        cr cn|||||||||080623s2008    dcua    sb    100 0 eng d  z  2008299620  z9780309110129 (pbk.)  z0309110122 (pbk.)  aCaPaEBRcCaPaEBR  a(OCoLC)608437399  an-us---14aRM302.5b.E44 2008eb04a615/.1028922200aEmerging safety scienceh[electronic resource] :bworkshop summary /cSally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.  aWashington, D.C. :bNational Academies Press,cc2008.  axvi, 134 p. :bill. (some col.).  aWorkshop held April 23-24, 2007 in Silver Spring, MD.  aIncludes bibliographical references (p. 115-116).  aAlso available via the World Wide Web.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2013.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aDrugszUnited StatesxSafety measuresvCongresses. 0aPharmaceutical biotechnologyzUnited StatesvCongresses. 0aDrugszUnited StatesxDesignvCongresses. 7aElectronic books.2local1 aRobinson, Sally.1 aPool, Robert.1 aGiffin, Robert B.2 aInstitute of Medicine (U.S.).bForum on Drug Discovery, Development, and Translation.2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10225174zAn electronic book accessible through the World Wide Web; click to view  c40987d40987